Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

158

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03BB06	SEEBRI BREEZHALER	B	Glycopyronium Bromide - 50mcg	50mcg	Capsule, inhalation	2,687,685 L.L
R01AD08	OTRIALLERGY	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L
R01AD09	METASONE	G	Mometasone furoate - 50mcg/actuation	50mcg/actuation	Spray	419,791 L.L
R03BA02	BUDENA	G	Budesonide - 50mcg/actuation	50mcg/actuation	Inhalation suspension	823,775 L.L
R03BA05	FLIXOTIDE EVOHALER	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Inhalation suspension	671,921 L.L
R01AD08	RINISONA	G	Fluticasone propionate - 50mcg/actuation	50mcg/dose	Spray, suspension	556,351 L.L
R01AD09	METASPRAY	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	349,399 L.L
R01AD09	MOMETASONE BIOGARAN	G	Mometasone furoate (monohydrate) - 50mcg/dose	50mcg/dose	Spray, suspension	501,253 L.L
D10AD06	AKLIEF	B	Trifarotene - 50mcg/g	50mcg/g	Cream	4,359,425 L.L
N02AB03	DUROGESIC	B	Fentanyl - 8.4mg	50mcg/h	Patch	3,019,614 L.L
S01EE01	XALATAN	B	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	704,173 L.L
S01EE01	MONOPROST	G	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	1,187,957 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 50mg	50mg	Tablet, film coated	378,964 L.L
A10BF01	GLUFIX	G	Acarbose - 50mg	50mg	Tablet	1,294,120 L.L
J05AX12	TIVICAY	B	Dolutegravir - 50mg	50mg	Tablet, film coated	54,508,037 L.L
J05AX12	TIVICAY	B	Dolutegravir - 50mg	50mg	Tablet, film coated	54,508,037 L.L
M01AB05	DICLO-DENK 50	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	893,655 L.L
M01AB05	DICLOGESIC	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	205,608 L.L
A10BH01	SITAGLIPTINE ARROW	G	Sitagliptin - 50mg	50mg	Tablet, coated	1,139,578 L.L
M01AB05	EPARDEX	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	223,974 L.L
A10BH02	GALVUS	B	Vildagliptin - 50mg	50mg	Tablet	950,097 L.L
M01AB05	EPARDEX	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	3,246,979 L.L
A10BH02	GLUNORM	G	Vildagliptin - 50mg	50mg	Tablet	611,448 L.L
M01AB05	OLFEN-50	G	Diclofenac sodium - 50mg	50mg	Tablet, gastroresistant	248,611 L.L
A10BH02	VILDAVITAE	G	Vildagliptin - 50mg	50mg	Tablet	665,202 L.L
M01AB05	PRIMAFENAC	G	Diclofenac sodium - 50mg	50mg	Tablet, enteric coated	223,974 L.L
A10BH02	VILDIAB	G	Vildagliptin - 50mg	50mg	Tablet	806,306 L.L
M01AB05	REMETHAN	G	Diclofenac sodium - 50mg	50mg	Tablet	196,201 L.L
N07XX02	RILUTEK	B	Riluzole - 50mg	50mg	Tablet, film coated	15,886,212 L.L
A10BH02	VLUDIN	G	Vildagliptin - 50mg	50mg	Tablet	767,910 L.L

...

158

...